2015). AXL has also been seen to be up‐regulated in idiopathic lung fibrosis and bemcentinib lead to a reduction in fibrosis development in two mouse lung fibrosis models (Espindola et al. 2018). Recently, a study using murine anti–GBM‐induced renal fibrosis models, showed less inflammation with reduced expression of cytokines and chemokines, and an improved renal function upon bemcentinib treatment. Accordingly, a similar effect was found in AXL knock out mice (Zhen et al. 2018). Here, AXL is linked to pulmonary fibrosis.